Dr Jonathon Arnold

Senior Lecturer Pharmacology, School of Medical Sciences Bosch Institute D06 - Blackburn Building The University of Sydney NSW 2006 Australia T: +61 2 9036 5361 F: +61 2 9351 7328 E:

On this page

Research interests | Publications

Research interests

Dr Jonathon is an internationally-recognised researcher in the pharmacology of cannabis and the cannabinoids (cannabis-like drugs).

Publications

2008

Jiwane, A., Holland, A., Soundappan, S., Arnold, J. Letters to the editor. Journal of paediatrics and child health. 2008; 44:747-749. [Abstract]

Holland, M., Allen, J., Arnold, J. Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1). European journal of pharmacology. 2008; 591:128-31. [Abstract]

Quinn, H., Matsumoto, I., Callaghan, P., Long, L., Arnold, J., Gunasekaran, N., Thompson, M., Dawson, B., Mallet, P., Kashem, M., Matsuda-Matsumoto, H., Iwazaki, T., McGregor, I. Adolescent Rats Find Repeated Delta(9)-THC Less Aversive Than Adult Rats but Display Greater Residual Cognitive Deficits and Changes in Hippocampal Protein Expression Following Exposure. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2008; 33:1113-26. [Abstract]

2007

Boucher, A., Hunt, G., Karl, T., Micheau, J., McGregor, I., Arnold, J. Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression. Neuroscience. 2007; 149:861-70. [Abstract]

McGregor, I., Arnold, J. Cannabis reward: biased towards the fairer sex?. British journal of pharmacology. 2007; 152:562-4. [Abstract]

Holland, M., Lau, D., Allen, J., Arnold, J. The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids. British journal of pharmacology. 2007; 152:815-24. [Abstract]

Boucher, A., Arnold, J., Duffy, L., Schofield, P., Micheau, J., Karl, T. Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol. Psychopharmacology. 2007; 192:325-336. [Abstract]

2006

Karl, T., Duffy, L., Boucher, A., Arnold, J., Schofield, P. Genetic animal models for neuregulin 1 - valuable tools for schizophrenia research?. Australian and New Zealand Journal of Psychiatry. 2006; 40:A115-A115. [Abstract]

Holland, M., Panetta, J., Hoskins, J., Bebawy, M., Roufogalis, B., Allen, J., Arnold, J. The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells. Biochemical pharmacology. 2006; 71:1146-54. [Abstract]

2005

Morley, K., Arnold, J., McGregor, I. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat. Progress in neuro-psychopharmacology & biological psychiatry. 2005; 29:648-57. [Abstract]

Arnold, J. The role of endocannabinoid transmission in cocaine addiction. Pharmacology, biochemistry, and behavior. 2005; 81:396-406. [Abstract]

2001

Arnold, J., Topple, A., Mallet, P., Hunt, G., McGregor, I. The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Brain research. 2001; 921:240-55. [Abstract]

Arnold, J., Hunt, G., McGregor, I. Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats. Life Sciences. 2001; 70:97-108. [Abstract]

[Show all 13 publications][Hide publications]